Sector ratings Incyte Corporation

Equities

Market Closed - Nasdaq Other stock markets 01:30:00 12/05/2026 am IST			5-day change	1st Jan Change
100.32 ^USD	+1.79%		+3.27%	+1.57%

07/05	Incyte Announces 24-Week Data For Opzelura Cream In Adults With Moderate Atopic Dermatitis	CI
02/05	Incyte Announces Fda Approval of Jakafi Xr Extended-Release Tablets for the Treatment of Myelofibrosis, Polycythemia Vera and Graft-Versus-Host Disease	CI

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Financial revisions	Global Valuation	Visibility	Consensus
INCYTE CORPORATION	1.97TCr		AA
REGENERON PHARMACEUTICALS, INC.	7.27TCr		BBB
UCB	5.25TCr		AA
SAMSUNG BIOLOGICS CO.,LTD.	4.66TCr		BBB
CSL LIMITED	4.21TCr		A
BIOGEN INC.	2.86TCr		AA
MODERNA, INC.	2.16TCr	-	BBB	-		-
INNOVENT BIOLOGICS, INC.	1.99TCr		AAA
SWEDISH ORPHAN BIOVITRUM AB	1.63TCr		AA
BRIDGEBIO PHARMA, INC.	1.32TCr	-	BB	-		-
ALTEOGEN INC.	1.25TCr		CCC
AXSOME THERAPEUTICS, INC.	1.12TCr	-	BBB	-		-
BIOMARIN PHARMACEUTICAL INC.	1.04TCr		BBB			-
KRYSTAL BIOTECH, INC.	901.23Cr	-	B	-		-
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	795.58Cr	-	BB	-		-	-
3SBIO INC.	712.96Cr		A
GRIFOLS, S.A.	653.84Cr		BB
SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD	652.12Cr	-	-	-		-	-
HEBEI CHANGSHAN BIOCHEMICAL PHARMACEUTICAL CO., LTD.	622.89Cr	-	B	-	-	-	-	-
SHANGHAI RAAS BLOOD PRODUCTS CO., LTD.	547.64Cr	-	A	-		-	-
Average	2.08TCr		A
Weighted average by Cap.			A